Product Overview
Xeno Laboratories Accutan is isotretinoin at 20 mg per tablet, a systemic retinoid derived from vitamin A and sold elsewhere under the name Accutane. It is not a training drug and it has no place in a cycle as such. It is included in this range because acne is one of the most common reasons a course gets abandoned, and isotretinoin is the one oral treatment that works on the cause rather than on the surface of the problem.
Its action is on the sebaceous gland. By shrinking gland size and cutting sebum output, the environment that feeds acne is removed rather than the visible lesion alone, which is why the course is measured in months. The half-life sits around ten to twenty hours depending on the source, and the effect is cumulative: treatment is planned towards a total milligram-per-kilogram figure rather than towards a fixed number of weeks. Standard doping panels do not test for it, though specialised methods can find it for weeks, and the exact window is not confirmed in the sources.
The reason a bodybuilding audience meets it at all is the hormonal environment. Courses built on the testosterone series, the trenbolone series or an oral such as Dianabol are the settings where severe acne shows up, and the compounds that are hardest on the liver make the retinoid a much heavier proposition to combine.
Dosage Protocol
The steps below reflect dermatological practice for the substance rather than a prescription, and the course is supervised in a clinical setting. The tablet is taken by mouth, ideally with a fatty meal, since absorption improves that way.
| Beginner | 10-20 mg a day for months, opened low to test tolerance |
| Intermediate | 0.5 mg per kilogram of bodyweight a day across the course |
| Advanced | Up to 1 mg per kilogram a day, towards a cumulative dose of 120-150 mg/kg |
| Female | Only with strict contraception; the drug is a teratogen and is forbidden in pregnancy |
| Administration | Oral with food containing fat; liver enzymes and lipids checked before and during the course |
| Duration | Months, continuing until the cumulative target is reached rather than a fixed date |
The fixed-dose reference is worth knowing because it underpins the cumulative idea. In a study of moderate to severe acne, a flat 20 mg a day was taken until a total of 120 mg per kilogram had been reached. That is why tablet size and course length are linked: a 20 mg unit makes a low daily starting step easy, and the endpoint is a total rather than a calendar date.
Suggested Protocols
Three settings describe how the tablet fits around a course. In each of them it is monitored rather than simply taken, and in each the liver check comes first.
What to Expect
- Sebum production and gland size fall over weeks to months, which is the mechanism rather than a hoped-for side effect.
- An initial flare of acne is typical at the start and is not a sign the course is failing.
- Dry lips, dry skin and dry eyes appear early and are almost universal, so lip balm and moisturiser are part of the plan.
- Improvement in the skin is judged over months, never over days.
- Photosensitivity rises, so sun exposure needs limiting and sun protection is not optional.
- Muscle and joint aches are possible during the course, particularly with heavy training.
Side Effects and Management
Monitoring and Follow-Up
There is no post-cycle role for this tablet and no axis to restore after it. What the course demands instead is laboratory oversight for the months it runs, plus a firm stopping rule based on the cumulative dose.
For readers managing the wider plan, the hormonal side of the acne is covered under the trenbolone series and the Proviron page, while Arimidex handles the estrogen question that sometimes runs alongside it.
